Steadfast and tenacious in our search for transformative therapies
TARA-002 for Lymphatic Malformations
TARA-002 is an investigational cell therapy based on the approved broad immunostimulant OK-432, which is approved in Japan and Taiwan for lymphatic malformations. read more
IV Choline Chloride for IFALD
An investigational phospholipid substrate replacement therapy for intestinal failure-associated liver disease (IFALD). read more
